ALPS Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-630
| Closed | -$312K | – | 1069 |
|
|
2022
Q2 | $312K | Sell |
630
-7
| -1% | -$3.47K | ﹤0.01% | 770 |
|
|
2022
Q1 | $359K | Buy |
637
+175
| +38% | +$98.6K | ﹤0.01% | 618 |
|
|
2021
Q4 | $349K | Buy |
462
+10
| +2% | +$7.55K | ﹤0.01% | 779 |
|
|
2021
Q3 | $337K | Sell |
452
-152
| -25% | -$113K | ﹤0.01% | 811 |
|
|
2021
Q2 | $389K | Hold |
604
| – | – | ﹤0.01% | 590 |
|
|
2021
Q1 | $345K | Buy |
604
+95
| +19% | +$54.3K | ﹤0.01% | 609 |
|
|
2020
Q4 | $297K | Sell |
509
-10
| -2% | -$5.84K | ﹤0.01% | 717 |
|
|
2020
Q3 | $268K | Sell |
519
-40
| -7% | -$20.7K | ﹤0.01% | 640 |
|
|
2020
Q2 | $252K | Sell |
559
-60
| -10% | -$27K | ﹤0.01% | 640 |
|
|
2020
Q1 | $217K | Sell |
619
-417
| -40% | -$146K | ﹤0.01% | 720 |
|
|
2019
Q4 | $383K | Sell |
1,036
-45
| -4% | -$16.6K | ﹤0.01% | 610 |
|
|
2019
Q3 | $360K | Buy |
+1,081
| New | +$360K | ﹤0.01% | 634 |
|